Inmaculada Rioja
Bicycle Therapeutics (United Kingdom)(GB)
Publications by Year
Research Areas
Protein Degradation and Inhibitors, Multiple Myeloma Research and Treatments, Ubiquitin and proteasome pathways, Histone Deacetylase Inhibitors Research, Immune Cell Function and Interaction
Most-Cited Works
- → Selective targeting of BD1 and BD2 of the BET proteins in cancer and immunoinflammation(2020)416 cited
- → Histone H3 lysine 9 di-methylation as an epigenetic signature of the interferon response(2012)165 cited
- → Potential novel biomarkers of disease activity in rheumatoid arthritis patients: CXCL13, CCL23, transforming growth factor α, tumor necrosis factor receptor superfamily member 9, and macrophage colony‐stimulating factor(2008)139 cited
- → Epigenetic modulation of type-1 diabetes via a dual effect on pancreatic macrophages and β cells(2014)85 cited
- → GSK789: A Selective Inhibitor of the First Bromodomains (BD1) of the Bromo and Extra Terminal Domain (BET) Proteins(2020)84 cited
- → Bromodomain Proteins Contribute to Maintenance of Bloodstream Form Stage Identity in the African Trypanosome(2015)80 cited
- → The structure based design of dual HDAC/BET inhibitors as novel epigenetic probes(2014)73 cited
- → BET protein inhibition shows efficacy against JAK2V617F-driven neoplasms(2013)68 cited
- → The Optimization of a Novel, Weak Bromo and Extra Terminal Domain (BET) Bromodomain Fragment Ligand to a Potent and Selective Second Bromodomain (BD2) Inhibitor(2020)63 cited
- → Brd4 bridges the transcriptional regulators, Aire and P-TEFb, to promote elongation of peripheral-tissue antigen transcripts in thymic stromal cells(2015)62 cited